Second Amendment to Equity AgreementEquity Agreement • August 14th, 2023 • Hesperos, Inc • Services-commercial physical & biological research
Contract Type FiledAugust 14th, 2023 Company IndustryThis Second Amendment (the “Second Amendment”) to the Equity Agreement (the “Agreement”) is effective as of the date of last signature (“Effective Date”) by and between Hesperos, Inc., a Delaware corporation authorized to conduct business in Florida as a foreign corporation, having an office and place of business at 12501 Research Parkway, Suite 100, Orlando, Florida 32826 (the “Company”) and the University of Central Florida Research Foundation, Inc., having an address and place of business at 12201 Research Parkway, Suite 501, Orlando, Florida, 32826 (“UCFRF”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
Fourth Amendment to Patent License AgreementLicense Agreement • August 14th, 2023 • Hesperos, Inc • Services-commercial physical & biological research
Contract Type FiledAugust 14th, 2023 Company IndustryThis Fourth Amendment (“Fourth Amendment”) to the License Agreement (License ID: 80471) (“License Agreement”) is effective July ___, 2023 (the “Fourth Amendment Effective Date”) by and between the University of Central Florida Research Foundation, Inc., having an address and place of business at 12201 Research Parkway, Suite 501, Orlando, Florida, 32826 (the “LICENSOR”), and Hesperos, Inc., a Delaware corporation authorized to conduct business in Florida as a foreign corporation, having an office and place of business at 12501 Research Parkway, Suite 100, Orlando, Florida 32826 (the “LICENSEE”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the License Agreement.